Diogo Martins-Branco

ESMO Guidance for Reporting Oncology real-World evidence (GROW)

Luís Castelo-Branco, Anna Pellat, Diogo Martins-Branco et al. · Annals of Oncology · 2023 · 183 citations · Full text

Medicine, Cancer Management, Cancer Registration +5

Cross-talk between mitochondria and proteasome in Parkinson’s disease pathogenesis

Diogo Martins-Branco · Frontiers in Aging Neuroscience · 2010 · 59 citations · Full text

Mitophagy, Mitochondrial Dysfunction, Proteasome +18

Ubiquitin proteasome system in Parkinson's disease: A keeper or a witness?

Diogo Martins-Branco, A. Raquel Esteves, Daniel Santos et al. · Experimental Neurology · 2012 · 43 citations · Full text

Amyotrophic Lateral Sclerosis, Medicine, Parkinson Disease +10

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

C. Benedikt Westphalen, Diogo Martins-Branco, Juliana Rodrigues Beal et al. · Annals of Oncology · 2024 · 42 citations · Full text

Factors associated with the aggressiveness of care at the end of life for patients with cancer dying in hospital: a nationwide retrospective cohort study in mainland Portugal

Diogo Martins-Branco, Sílvia Lopes, R. Canário et al. · ESMO Open · 2020 · 23 citations · Full text